Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vincristine administration method trial in children with acute lymphoblastic leukemia
NL-OMON29651Not yet recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- May 2014
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of vincristine in acute lymphoblastic leukemia (ALL) (2 arms), sponsored by Amsterdam University Medical Center. Primary endpoint: Peripheral neuropathy. Planned start May 2014; status: not yet recruiting.
02
Drugs
vincristine
03
Conditions
acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on NL-OMON29651.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON29651.